What one share of Niagen Bioscience holds
On May 21, 2008, Cody Resources, Inc., a Nevada corporation and a public company, (Cody) entered into an Agreement and Plan of Merger (Merger Agreement), by and among Cody, CDI Acquisition, Inc., a California corporation and wholly-owned subsidiary of Cody (Acquisition Sub), and ChromaDex, Inc.
Niagen Bioscience’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.52 |
|---|---|
| Profit | $0.19 |
| Cash and investments | $0.85 |
| Book value | $1.05 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | $0.47 | −$0.12 | $0.01 | −$0.18 | — | $0.24 |
| 2011 | $0.32 | −$0.36 | $0.01 | −$0.17 | — | $0.11 |
| 2012 | $0.36 | −$0.39 | $0.00 | −$0.32 | — | $0.13 |
| 2013 | $0.30 | −$0.12 | $0.00 | −$0.12 | — | $0.16 |
| 2014 | $0.43 | −$0.15 | $0.00 | −$0.08 | — | $0.11 |
| 2015 | $0.50 | −$0.08 | $0.01 | −$0.07 | — | $0.15 |
| 2016 | $0.58 | −$0.08 | $0.04 | −$0.12 | — | $0.27 |
| 2017 | $0.48 | −$0.26 | $0.03 | −$0.25 | — | $0.98 |
| 2018 | $0.57 | −$0.61 | $0.02 | −$0.40 | — | $0.49 |
| 2019 | $0.81 | −$0.56 | $0.01 | −$0.37 | — | $0.34 |
| 2020 | $0.97 | −$0.33 | — | — | — | $0.27 |
| 2021 | $1.00 | −$0.40 | — | — | — | $0.47 |
| 2022 | $1.03 | −$0.24 | — | — | — | $0.38 |
| 2023 | $1.11 | −$0.07 | — | — | — | $0.38 |
| 2024 | $1.27 | $0.11 | — | — | — | $0.60 |
| 2025 | $1.51 | $0.20 | — | — | — | $0.96 |
Common questions about Niagen Bioscience
How much does one share of Niagen Bioscience earn?
Over the last 12 months, each share of Niagen Bioscience earned $0.19 of profit on $1.52 of sales, keeping about 12¢ of every $1 (profit margin).
Does Niagen Bioscience pay a dividend?
Niagen Bioscience didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Niagen Bioscience’s book value per share?
Niagen Bioscience’s book value is $1.05 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Niagen Bioscience have?
Each share of Niagen Bioscience has $0.85 of cash and investments, as of June 30, 2026.
Has Niagen Bioscience bought back shares?
Niagen Bioscience’s share count rose about 431% from 2010 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.